Birdwatch Note Rating
2023-03-16 19:23:22 UTC - NOT_HELPFUL
Rated by Participant: C559E982739691E2EFE38F13A971AA3B8B28A962694A86631FB41C5B2274E6C4
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details